Liver microRNA-21 is overexpressed in non-alcoholic steatohepatitis and contributes to the disease in experimental models by inhibiting PPARα expression-Reference-Cited by-同舟云学术

Liver microRNA-21 is overexpressed in non-alcoholic steatohepatitis and contributes to the disease in experimental models by inhibiting PPARα expression

Published:2015-09-03 Issue:11 Volume:65 Page:1882-1894
ISSN:0017-5749
Container-title:Gut
language:en
Short-container-title:Gut

Author:

Loyer Xavier,Paradis Valérie,Hénique Carole,Vion Anne-Clémence,Colnot Nathalie,Guerin Coralie L,Devue Cécile,On Sissi,Scetbun Jérémy,Romain Mélissa,Paul Jean-Louis,Rothenberg Marc E,Marcellin Patrick,Durand François,Bedossa Pierre,Prip-Buus Carina,Baugé Eric,Staels Bart,Boulanger Chantal M,Tedgui Alain,Rautou Pierre-Emmanuel

Publisher

BMJ

Subject

Gastroenterology

Reference49 articles.

1. The diagnosis and management of non-alcoholic fatty liver disease: Practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association;Chalasani;Hepatology,2012

2. A position statement on NAFLD/NASH based on the EASL 2009 special conference;Ratziu;J Hepatol,2010

3. Racial and ethnic distribution of nonalcoholic fatty liver in persons with newly diagnosed chronic liver disease;Weston;Hepatology,2005

4. MicroRNAs: target recognition and regulatory functions;Bartel;Cell,2009

5. MicroRNAs in liver disease;Wang;Gastroenterology,2012

Cited by 138 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. MicroRNAs in Anticancer Drugs Hepatotoxicity: From Pathogenic Mechanism and Early Diagnosis to Therapeutic Targeting by Natural Products;Current Pharmaceutical Biotechnology;2024-10

2. Exosome prospects in the diagnosis and treatment of non-alcoholic fatty liver disease;Frontiers in Medicine;2024-07-31

3. Impact of miR-222-3p-mediated downregulation of arylacetamide deacetylase on drug hydrolysis and lipid accumulation;Drug Metabolism and Pharmacokinetics;2024-06

4. The advent of RNA-based therapeutics for metabolic syndrome and associated conditions: a comprehensive review of the literature;Molecular Biology Reports;2024-04-05

5. Tenascin-X is increased with decreased expression of miR-378a-5p and miR-486-5p in mice fed a methionine-choline-deficient diet that induces hepatic fibrosis;Biomedical Research;2024-03-22